EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A prospective study on serum citrate levels and clinical correlations in patients receiving regional citrate anticoagulation

Harmony H M To iD, Arthur M C Kwan, Natalie Y Y Leung, W M Chan, C W Ngai iD, Alfred S K Wong iD, Polly N W Tsai, Tammy S K Ma, Irene Yam, Pauline Yeung Ng iD, Desmond Y H Yap iD

Clinical Kidney Journal · 06.02.2023 · 16 (2) · 285-292

DOI: 10.1093/ckj/sfac223 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Kidney Journal, online erschienen am 15.10.2022. Verfasst von Harmony H M To und 10 weiteren Autor:innen. Beteiligte Einrichtung: Adult Intensive Care Unit, Queen Mary Hospital, Hong Kong. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Hong Kong College of Physicians Young Investigator, New Territories West Research Governance Committee Research, Wai Im Charitable Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Current ways to diagnose citrate accumulation (CA) in patients receiving regional citrate anticoagulation (RCA) continuous renal replacement therapy (CRRT) are confounded by various clinical factors. Serum citrate measurement emerges as a more direct way to diagnose CA, but its clinical utility and optimal cut-off values remain undefined. This study examined serum citrate kinetics and its diagnostic performance for CA in patients receiving RCA CRRT.

Methods

A multicentre prospective study was carried out in two tertiary referral centre intensive care units in Hong Kong with serum citrate levels measured at baseline and 2, 6, 12, 24, 36, 48 and 72 h after initiation of RCA CRRT and their relationships with the development of CA.

Results

Among the 133 patients analysed, 18 patients (13.5%) developed CA. The serum citrate levels at baseline and 2, 6 and 12 h after initiation of RCA CRRT in patients who had CA were significantly higher than the non-CA group (P < .001 for all). The CA group also had higher serum citrate levels than the non-CA group {median 0.93 mmol/L [interquartile range (IQR) 0.81–1.16) versus 0.37 mmol/L (IQR 0.26–0.57), P < .001}. Using a cut-off of 0.85 mmol/L, the serum citrate level had a sensitivity of 0.77 and a specificity 0.96 for the diagnosis of CA [area under the receiver operating characteristics curve (AUROC) 0.90, P < .001]. The 2-h and 6-h serum citrate levels had good discriminatory abilities for predicting subsequent development of CA (AUROC 0.86 and 0.83 for 2-h and 6-h citrate levels using cut-off values of 0.34 and 0.63 mmol/L, respectively; P < .001).

Conclusion

Serum citrate levels were significantly higher in patients with CA compared with patients without CA. Serum citrate levels showed good performance in diagnosing and predicting the development of CA.

Schlagwörter

Stichwörter der Autor:innen

citrate accumulationcitrate toxicityregional citrate anticoagulationserum citrate level

Autor:innen und Institutionen

  • Adult Intensive Care Unit, Queen Mary Hospital, Hong Kong.
  • Department of Anaesthesia and Intensive care, Tuen Mun Hospital, Hong Kong.
  • Division of Nephrology, Department of Medicine, University of Hong Kong, Hong Kong.
  • Division of Respiratory and Critical Care Medicine, Department of Medicine, University of Hong Kong, Hong Kong.

ORCID-Profile: Harmony H M To, C W Ngai, Alfred S K Wong, Pauline Yeung Ng, Desmond Y H Yap

Förderung

  • Hong Kong College of Physicians Young Investigator
  • New Territories West Research Governance Committee Research
  • Wai Im Charitable Foundation
  • Chan Sui Kau Family Benefits and Charitable Foundation

Zitieren

APA

To, H. H. M., Kwan, A. M. C., Leung, N. Y. Y., Chan, W. M., Ngai, C. W., Wong, A. S. K., Tsai, P. N. W., Ma, T. S. K., Yam, I., Ng, P. Y., & Yap, D. Y. H. (2023). A prospective study on serum citrate levels and clinical correlations in patients receiving regional citrate anticoagulation. Clinical Kidney Journal, 16(2), 285-292. https://doi.org/10.1093/ckj/sfac223

Vancouver

To HHM, Kwan AMC, Leung NYY, Chan WM, Ngai CW, Wong ASK, et al. A prospective study on serum citrate levels and clinical correlations in patients receiving regional citrate anticoagulation. Clinical Kidney Journal. 2023;16(2):285-292. doi:10.1093/ckj/sfac223

BibTeX
@article{To2023,
  author = {To, Harmony H M and Kwan, Arthur M C and Leung, Natalie Y Y and Chan, W M and Ngai, C W and Wong, Alfred S K and Tsai, Polly N W and Ma, Tammy S K and Yam, Irene and Ng, Pauline Yeung and Yap, Desmond Y H},
  title = {A prospective study on serum citrate levels and clinical correlations in patients receiving regional citrate anticoagulation},
  journal = {Clinical Kidney Journal},
  year = {2023},
  volume = {16},
  number = {2},
  pages = {285--292},
  doi = {10.1093/ckj/sfac223}
}
Kostenlos starten →